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How the photoepilation story began {#sec1-1}
==================================

Two landmark dates mark the history of photoepilation and, generally, the application of pulsed light sources in dermatology and aesthetic dermatology.

The introduction of the selective photothermolysis concept in 1984 was the first landmark event. It was a crucial step that deserved a *Science* paper and opened the way to major advances in photoepilation technology over the past quarter of a century. In the words of the authors, *selective damage to pigmented structures, cells, and organelles in vivo with suitably brief pulses of selectively absorbed radiation* overcomes the need of precise aiming because *inherent optical and thermal properties provide target selectivity*.^[@ref1]^

Proper selection of wavelength in the recommended visible to near-infrared region up to about 1100-1200 nanometers (nm), pulse duration, and the energy density administered over the exposure time or fluence are the three paramount parameters. Compromise among these three parameters is crucial to ensure deep dermal penetration, maximum thermal damage to the melanin chromophore, and minimum absorption by oxyhemoglobin and water.^[@ref2],[@ref3]^

The second landmark date was 1996. In that year the American Food and Drug Administration approved the first ruby-laser device for hair removal. It was so feasible to overcome at least the most severe risks of scarring or hyperpigmentation inherent to electrolysis, performed since 1875 and the only other technology then available for long-term destruction of follicles.^[@ref4]^ Today light-based hair removal technologies are based either on narrow-waveband lasers or high-intensity incoherent and multi-chromatic pulsed light (intense pulsed light, IPL). Long-term unwanted hair removal has become one of the fastest growing, nonsurgical aesthetic procedures in Europe and all over the world.^[@ref2]^ Specifically as regards broad-spectrum IPL epilation based on noncoherent 590-1200 nm light sources - typically xenon flash lamps emitting energy in short bursts and operated with cut-off filters - already in 2014 it had become the seventh most popular procedure among plastic surgeons and related specialists, according to the American Society for Aesthetic Plastic Surgery.^[@ref5]^

The relative merits and liabilities of intense pulsed light and laser systems {#sec1-2}
=============================================================================

Any chromophore-based photoepilation technology should be an efficient compromise between dermal penetration and targeting of the endogenous melanin in the hair shaft, the outer sheath of the hair follicle infundibulum and the matrix areas ([Figure 1](#fig001){ref-type="fig"}). The hair bulb and the germinal matrix are rich in amelanotic stem cells that are most efficiently targeted during the anagen phase of development, when the non-pigmented germinal matrix is closest to pigmented structures.^[@ref2],[@ref6]^ IPL and laser devices that operate in the red or near-infrared wavelength region like the long-pulsed 755-nm alexandrite laser, the long-pulsed 800, 810-nm diode laser and the long-pulsed 1064-nm neodymium:yttrium-aluminium-garnet (Nd:YAG) laser allow for the overall best compromise.^[@ref6],[@ref9]^

The Nd:YAG laser, less effective in light-skinned subjects, could find a somewhat limited but elective niche in dark-skin individuals (Fitzpatrick skin type IV-VI), especially with pseudofolliculitis barbae.^[@ref8],[@ref10]^ The Nd:YAG has the least overall hair removal efficiency while the alexandrite and diode lasers are the best for extensive use. However, post-laser pigmentation may be troublesome with alexandrite devices whilst the need for high levels of fluence increase the risk of complications with diode systems in darker skin types.^[@ref11]^

IPL systems are possibly more technique-dependent to limit the risk of local pain and irritation. However, they offer the benefit to be highly versatile due to the wide range of emitted wavelengths when hair or skin colors are not ideal for laser photoepilation.^[@ref8]^ The hair removal benefits of IPL technologies are most significant in individuals with dark hair and light skin, a common Caucasian phenotype and the dominant phenotype in East Asia. Hair that is growing after epilation is also thinner and lighter in color, and thus often another ideal candidate for IPL re-treatment several months after the first IPL or laser procedure.^[@ref8]^ A decade ago, there had been some isolated criticism of IPL, related to the need for early IPL devices to be very highly powered to destroy hair.^[@ref12]^ Yet, a decade ago is much time in this rapidly evolving field. Some recent intra-patient-controlled split-face comparisons seem to indicate that IPL could offer some benefits compared with laser devices in terms of hair reduction, patient satisfaction, and local pain. A 2013 left-to-right split-face assessor-blinded study compared a IPL (λ~em~=600-950 nm) and a diode laser device for removal of unwanted axillary hair (6 sessions at 4-week intervals in 30 subjects with skin type II-III; hair counts assessed with close-up photographs).^[@ref13]^ The 3- and 12-month mean hair reduction was slightly higher with the diode laser system (59.7% *vs* 42.4% and 69.2% *vs* 52.7% from baseline for laser and IPL treatments, respectively), but at significantly higher pain cost compared with the almost pain-free IPL technology (3.7±2.1 *vs* 1.6±1.4, respectively; 10-cm visual analogue scale).^[@ref13]^ Similar results were seen in a double-blind, intra-patient-controlled randomized study of axillary hair removal in 21 women after application (6 sessions) of a diode laser on one axilla and IPL on the other one. The number of hair shafts was lastingly and similarly reduced with both hair reduction systems, but local pain was significantly more disturbing with the diode laser.^[@ref14]^

Ultra-refining the chromophore targeting process {#sec1-3}
================================================

Some advanced IPL systems are being introduced that allow to concentrate almost all emitted energy in very narrow wavelengths selected within the ample waveband of IPL xenon flash lamps. For instance, an advanced Italian IPL-derived technology \[IFL™ (Incoherent Fast Light), Novavision Group S.p.A., 20826 Misinto (MB), Italy\], when used in photoepilation mode at up to 3.3 light pulses per second, allows an extremely high selection of the wide xenon lamp waveband by focusing the energy emission on 700, 810 and 890 nm wavelengths. Ultraviolet emissions are preliminary filtered away by default by the ultra-transparent cerium-supplemented borosilicate glass of the IFL™ light emitter acting together with a permanently installed 420-nm cut-off filter. The local safety allowed by wavelength selection is further improved by avoiding all contacts of the device with the skin. At the same time, the technological improvements of the system allow to increase the number of spots up to 210,000.

Summarizing, the photoepilation story that began in 1984 with a landmark *Science* paper is still going on and technology is still making strong headways; and not only in photoepilation.

The expanding scope for intense pulsed light beyond photoepilation {#sec1-4}
==================================================================

In 1990, a high-intensity flash lamp was first described as a new tool for treating vascular lesions; the first IPL medical device aimed to benign vascular lesions was commercially launched in 1994.^[@ref15]^

Since those years, many features of first-generation IPL devices have undergone technological refinements, with special reference to the xenon gas-discharge flash lamp and the electronic control of the capacitor banks. Such capacitors store and discharge the electrical energy that generates the pulsed polychromatic high-intensity light. The computer-assisted selection of treatment settings is also being steadily improved and water filters have been developed to absorb most infrared radiation. The IFL™ technology previously discussed is an example of such engineering improvements.

Beyond photoepilation, the versatile range of IPL wavelengths ([Figure 2](#fig002){ref-type="fig"}) has been applied to a wide spectrum of dermatological conditions, such as photodamaged skin, acne vulgaris, epidermal and dermal pigmented and vascular lesions, angiokeratoma, and hypertrophic scars and keloids. Available evidences suggest IPL might be the treatment of choice in at least some of such cutaneous disorders.^[@ref16],[@ref17]^

The range of cutaneous disorders amenable to IPL treatment continues to widen. A recent evidence-based set of recommendations, based on the highest level of evidence available to guide physicians in the IPL treatment of dermatologic diseases, found Level 1 evidence for melasma, acne vulgaris, and telangiectasia; Level 2 evidence for lentiginous disease, acne rosacea, capillary malformations, actinic keratoses, and sebaceous gland hyperplasia; Level 3 or lower evidence for poikiloderma of Civatte, venous malformations, infantile hemangiomas, hypertrophic scars and keloids, superficial basal cell carcinoma, and Bowen's disease.^[@ref18]^ Other dermatological disorders have also been treated with IPL with satisfactory results: port-wine stains, a common congenital vascular malformation occurring in up to 25% of individuals since infancy, Becker's nevus, a male-predominant benign hypermelanotic birthmark on the shoulders, chest or lower back, and pilonidal or sacro-coccygeal cysts containing hair and skin debris.^[@ref19]^ Disseminated porokeratosis, presenting as asymptomatic or mildly itching atrophic plaques surrounded by an hyperkeratotic border histologically known as cornoid lamella, and the soft warty or squamous crusted, yellow-brown surface of seborrheic keratosis have also been treated quite successfully with IPL.^[@ref19]^

Biological mechanisms of intense pulsed light phototherapy and photorejuvenation {#sec1-5}
================================================================================

Findings in photoaging due to chronic exposure to UV sunlight include wrinkling and rough skin texture, altered pigmentation and loss of elasticity. Even with first-generation IPL devices, improved texture and telangiectasias were reported 4 years after IPL treatment (median, 3 sessions) by, respectively, 83% and 82% of individuals with skin types I-IV; improvements in mottled pigmentation persisted in 79% of treated subjects.^[@ref20]^ As regards the biological mechanisms underlying IPL photorejuvenation, epithelial and dermal structures appear to be preserved in the weeks following the IPL procedure with no further lesion to the sun-damaged skin.^[@ref21]^ Cosmetic benefits are thus most probably unrelated to destruction of pre-existing dermal structures. Conversely, increased collagen deposition in the upper papillary and upper reticular dermis and a more neat arrangement of elastin fibers have long been known to have a role in the clinical and aesthetic improvements.^[@ref21],[@ref22]^

Dermal dendritic cells are likely to be the biological target in IPL photorejuvenation, as suggested by the expression of the heat-induced protein hsp70 (Heat Shock Protein 70 kilodaltons) and procollagen 1 by these cells as markers of their activation. Activation of dermal dendritic cells might be the underlying event that ultimately leads to collagen deposition by dermal fibroblasts.^[@ref21]^ Advanced IPL developments are being devised to activate such cellular photorejuvenation mechanisms. A most recent example is the PhotoActivating System (PhAS™) program of the IFL™ technology, which produces a long continuous pulse, adjustable from 2 to 4 seconds, of very low energy to maximize efficiency of action on dermal cells.

Some examples of the intense pulsed light efficacy in dermatological disorders {#sec1-6}
==============================================================================

As regards phototherapy of dyschromia, improvements were similar in a same-patient, spit-face study of treatment of dark and light lentigines and vessels less and greater than 0.6 mm with pulsed dye laser and IPL, three sessions at 3- to 4-week intervals (responder patients, 86.5, 65, 85 and 38% *vs* 82, 62.5, 78.5 and 32.5%, respectively, with pulsed dye laser and IPL). However, treatment times and assessment of local pain significantly favored IPL (mean third session times; pulsed dye laser 7.7 minutes, IPL 4.6 minutes, P=0.005; mean pain ratings, pulsed dye laser 5.8 minutes, IPL 3.1 minutes, P=0.007).^[@ref23]^

In another study with benign pigmented lesions, 96% of patients with lentigo solaris and melanocytic nevi showed pigment reduction with an average clearance of 74.2% and 66.3% of lesions, respectively. Superficial crusting and ulceration (average diameter on day 5, 3.7 mm) followed by some degree of erythema were observed in most treated lesions, but healing was complete within 30 days.^[@ref24]^ [Figure 3](#fig003){ref-type="fig"} illustrates the IPL and IFL™ wavelength range ideally suited to phototherapy of cutaneous dyschromia.

Skin vascular lesions such as facial telangiectasia and port-wine stains have traditionally been treated with the pulsed dye laser. Such lesions are another indications where IPL is at least as effective as the gold standard. IPL may even be considered first choice because it is often successful when the pulsed dye laser fails. The mechanism of action is related to selective absorption of IPL energy by hemoglobin within target blood vessels.^[@ref25],[@ref26]^ In patients with port-wine stains resistant to multiple pulsed dye laser treatments, almost half of the patients (46.7%) responded to four IPL sessions with a more than 50% reduction of lesions. The average clearance for the responders was 83.9±9.5%. Most of such IPL responders (85.7%) obtained reductions between 75% and 100% of their basal stains; only lesions in the central part of the V~2~ face dermatome failed to respond. Preference for IPL over multiple pulsed dye laser was expressed by 93.5% of the patients.^[@ref26]^ IPL technologies have also been long used in the treatment of acne vulgaris. IPL seems to act by targeting both inflammation and sebaceous glands. With a few treatment sessions, IPL reduces the density of the inflammatory cell infiltrate and the surface area of sebaceous glands, especially in more inflammatory acne variants, in parallel with reduction of the Cardiff Acne Disability Index or other scores of clinical impact.^[@ref27]^

The molecular mechanism of such powerful anti-inflammatory action could be a novel anti-Tumor Necrosis Factor-α effect independent of interleukin-10 up-regulation.^[@ref28]^ Selective photothermolysis of blood vessels that supply sebaceous glands could also contribute to the acne-suppressing efficacy by reducing the sebum secretion rate. Such photodynamic effect could be mediated by energy absorption by coproporphyrins produced by *Propionibacterium acnes* (absorption peaks: 400, 510, 542, 578, 630, 665 nm) with generation of bacteridical reactive oxygen species.^[@ref29]^

All light-based therapies, including IPL, are especially effective in treating inflammatory acne vulgaris with minimal side effects. This was most recently confirmed in a 2016 single-blind, split-face clinical trial that compared the clinical efficacy of 3 sessions of IPL on the right side of the face and 1,064-nm Nd:YAG laser on the left side at 4-weeks intervals in 74 individuals with mild to severe facial acne. The reduction of inflammatory papules, pustules, nodules and cysts was similar with both phototherapy strategies (--67.1% and --70.2%, respectively, with IPL and Nd:YAG laser) while response of non-inflammatory comedones was equally modest (--18.3% and --19.3%, respectively).^[@ref30]^

Summarizing {#sec1-7}
===========

Versatility in treating many dermatological conditions as well as lower commercial costs and more robust technology are strong advantages for IPL technologies compared to laser devices. This may be true for both photoepilation and treatment of several skin disorders, for which IPL is often the first-choice option. The large spot sizes allowed by IPL shorten the time needed for photorejuvenation sessions while the troublesome need to apply an optical coupling gel has been eliminated with the most advanced pulsed light devices.^[@ref29]^

IPL technologies developed over the very last years like IFL™ have also eliminated the emission of sigmoidal-shaped pulses, another weak point of older IPL devices. Shifts in spectral and fluence distribution within the pulse are unavoidable with non-square-shaped pulses. Thanks to the large capacitor banks in advanced IPL devices, variable current are no longer delivered to the xenon flash lamp and roughly square-shaped pulses are dependably emitted. Some minor difficulties with handling and the weight of the handpiece incorporating both the lamp and the lamp-cooling system are a little price that has still to be paid for all the benefits of the most advanced IPL technologies.^[@ref29]^ It does not seem a heavy price to pay.

![A) Relationship between intense pulsed light (IPL) and laser wavelength and depth of penetration into the epidermis and dermis. At wavelengths within the low absorption index of water (400 to 1000 nm, visible and near-infrared spectrum), dispersal within the dermis decreases with increasing wavelengths whilst penetration deepens and photothermolytic effects become stronger. The IPL wavelength window is about 590 to 1,200 nm. The 694-nm ruby laser is no longer used in photoepilation because of strong absorption by melanin and high risk of adverse effects in tanned and darker skin types and hypopigmented areas observed even in skin type II. Nd:YAG: neodymium:yttriumaluminium-garnet.^[@ref6],[@ref1]^1 B) Diagram illustrating the overall relationship between wavelengths in the visible and near-infrared spectrum and electromagnetic energy absorption by melanin. Energy absorption by the chromophore and thermal biological effects are high in the low visible spectrum and decrease with increasing wavelengths. In spite of high dermal penetration, wavelengths higher than 1,100 nanometers (nm) are less useful for selective photothermolysis.^[@ref8]^](dr-9-1-7116-g001){#fig001}

![Light absorption spectra of skin chromophores (melanin and oxyhemoglobin) and water in visible and infrared wavelengths with evidence of the strongest energy emission peaks of IPL flash-lamp devices within their operating visible and near-infrared wavelengths. In advanced IPL devices like Incoherent Fast Light™ (IFL™), the emitted light energy is selectively concentrated within these energy-emission peaks whilst the ultra-transparent low-residue water in the closed-loop cooling system extensively filters away infrared wavelengths longer than 900 nanometers.](dr-9-1-7116-g002){#fig002}

![Light absorption spectra of skin chromophores (melanin and oxyhemoglobin) and water in visible and infrared wavelengths with evidence of the useful range of wavelengths in the IPL phototherapy of disorders of cutaneous pigmentation.](dr-9-1-7116-g003){#fig003}

[^1]: Sponsor: Novavision Group S.p.A., Misinto (MB), Italy.
